- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 645.37M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 623.92M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 586.51M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.73M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.27M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $47.14M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $19.32M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $24.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $50.71M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $22.29M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $24.79M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $27.18M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.49M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.92M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.83M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $49.71M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $21.16M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $52.63M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $24.12M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $580K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $750K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.13M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |